Dispatches from AAPS 2014
GSK ‘moves best people’ to keep Ebola vaccine manufacture in-house
GSK is keeping its Ebola vaccine production in-house, despite previously leaked documents which suggested the company could not ramp up volume of BS-2 manufacturing without impacting its other vaccine lines.